Cogent Biosciences, Inc. (COGT)

NASDAQ: COGT · Real-Time Price · USD

34.96

-0.42 (-1.19%)

At close: May 29, 2026, 4:00 PM EDT

35.04

+0.08 (0.23%)

After-hours: May 29, 2026, 7:47 PM EDT

Cogent Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	5,975	6,477	1,053	506	1,042	376
Market Cap Growth	974.69%	515.35%	107.85%	-51.41%	177.29%	3.46%
Enterprise Value	5,347	5,903	892	318.2	866.98	242.4
Last Close Price	34.96	35.52	7.80	5.88	11.56	8.58
PB Ratio	11.00	10.18	4.11	1.96	4.08	1.75
P/TBV Ratio	8.12	7.20	3.16	1.82	2.66	1.55
Debt / Equity Ratio	0.39	0.37	0.06	0.07	0.07	0.00
Net Debt / Equity Ratio	-1.03	-1.04	-1.05	-0.96	-0.94	-1.01
Net Debt / EBITDA Ratio	1.76	2.01	0.99	1.21	1.69	2.94
Net Debt / FCF Ratio	2.19	2.49	1.29	1.58	1.91	3.58
Quick Ratio	14.94	14.08	5.15	6.96	9.66	12.86
Current Ratio	15.14	14.23	5.32	7.09	9.87	13.04
Return on Equity (ROE)	-56.96%	-73.70%	-99.54%	-74.94%	-59.69%	-32.20%
Return on Assets (ROA)	-39.34%	-52.68%	-86.05%	-67.77%	-55.48%	-31.28%
Return on Invested Capital (ROIC)	1590.18%	1714.48%	23197.90%	-1447.71%	-1596.27%	-3844.83%
Return on Capital Employed (ROCE)	-42.13%	-58.19%	-100.81%	-75.79%	-60.47%	-33.37%
Buyback Yield / Dilution	-6.75%	-24.11%	-30.38%	-35.61%	-51.66%	-249.51%
Total Shareholder Return	-6.75%	-24.11%	-30.38%	-35.61%	-51.66%	-249.51%

SEC Filings: 10-K · 10-Q